Literature DB >> 24119848

APOL1 and nephropathy progression in populations of African ancestry.

Barry I Freedman.   

Abstract

Marked familial aggregation of chronic kidney disease suggests that inherited factors play a major role in nephropathy susceptibility. Molecular genetics analyses have identified a number of genes reproducibly associated with a broad range of renal phenotypes. Most associations show polygenic inheritance patterns with limited effect size. In contrast, genetic association between the apolipoprotein L1 (APOL1) gene and several severe nondiabetic forms of kidney disease in African Americans approach Mendelian inheritance patterns and account for a large proportion of glomerulosclerosis in populations of African ancestry. Emerging data support an important role for APOL1 in the progression of diverse etiologies of kidney disease, in concert with requisite environmental (gene*environment) and inherited (gene*gene) interactions. This article reviews the current status of APOL1-associated nephropathy and discusses research questions under active investigation in the search for a cure for these severe and often progressive kidney diseases.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOL1; African American; FSGS; HIV; kidney disease; progression

Mesh:

Substances:

Year:  2013        PMID: 24119848      PMCID: PMC3876798          DOI: 10.1016/j.semnephrol.2013.07.004

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  51 in total

1.  Living donor nephrectomy: understanding long-term risk in minority populations.

Authors:  R S Gaston; C J Young
Journal:  Am J Transplant       Date:  2010-12       Impact factor: 8.086

Review 2.  The spectrum of MYH9-associated nephropathy.

Authors:  Meredith A Bostrom; Barry I Freedman
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

3.  African American living-kidney donors should be screened for APOL1 risk alleles.

Authors:  David M Cohen; Anuja Mittalhenkle; David L Scott; Carlton J Young; Douglas J Norman
Journal:  Transplantation       Date:  2011-10-15       Impact factor: 4.939

Review 4.  The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.

Authors:  Barry I Freedman; Jeffrey B Kopp; Carl D Langefeld; Giulio Genovese; David J Friedman; George W Nelson; Cheryl A Winkler; Donald W Bowden; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 10.121

5.  MYH9 and APOL1 are both associated with sickle cell disease nephropathy.

Authors:  Allison E Ashley-Koch; Emmanuel C Okocha; Melanie E Garrett; Karen Soldano; Laura M De Castro; Jude C Jonassaint; Eugene P Orringer; James R Eckman; Marilyn J Telen
Journal:  Br J Haematol       Date:  2011-09-13       Impact factor: 6.998

6.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

7.  Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with the progression of IgA nephropathy in Chinese.

Authors:  Wenrong Cheng; Xujie Zhou; Li Zhu; Sufang Shi; Jicheng Lv; Lijun Liu; Hong Zhang
Journal:  Nephrol Dial Transplant       Date:  2011-01-18       Impact factor: 5.992

8.  Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.

Authors:  Barry I Freedman; Pamela J Hicks; Meredith A Bostrom; Mary E Cunningham; Yongmei Liu; Jasmin Divers; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Carl D Langefeld; Donald W Bowden
Journal:  Kidney Int       Date:  2009-01-28       Impact factor: 10.612

9.  Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.

Authors:  Rainer G Ruf; Anne Lichtenberger; Stephanie M Karle; Johannes P Haas; Franzisco E Anacleto; Michael Schultheiss; Isabella Zalewski; Anita Imm; Eva-Maria Ruf; Bettina Mucha; Arvind Bagga; Thomas Neuhaus; Arno Fuchshuber; Aysin Bakkaloglu; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

10.  HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.

Authors:  Mohamed G Atta; Michelle M Estrella; Michael Kuperman; Matthew C Foy; Derek M Fine; Lorraine C Racusen; Gregory M Lucas; George W Nelson; Andrew C Warner; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Kidney Int       Date:  2012-04-11       Impact factor: 10.612

View more
  13 in total

Review 1.  Social Determinants of Racial Disparities in CKD.

Authors:  Jenna M Norton; Marva M Moxey-Mims; Paul W Eggers; Andrew S Narva; Robert A Star; Paul L Kimmel; Griffin P Rodgers
Journal:  J Am Soc Nephrol       Date:  2016-05-13       Impact factor: 10.121

2.  APOL1 Genotype and Renal Function of Black Living Donors.

Authors:  Mona D Doshi; Mariella Ortigosa-Goggins; Amit X Garg; Lihua Li; Emilio D Poggio; Cheryl A Winkler; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2018-01-16       Impact factor: 10.121

Review 3.  The conundrums of chronic kidney disease and aging.

Authors:  Richard J Glassock; Aleksandar Denic; Andrew D Rule
Journal:  J Nephrol       Date:  2016-11-25       Impact factor: 3.902

Review 4.  Solid Organ Transplantation in HIV-Infected Recipients: History, Progress, and Frontiers.

Authors:  William A Werbel; Christine M Durand
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

Review 5.  Socioeconomic disparities in chronic kidney disease.

Authors:  Susanne B Nicholas; Kamyar Kalantar-Zadeh; Keith C Norris
Journal:  Adv Chronic Kidney Dis       Date:  2015-01       Impact factor: 3.620

Review 6.  APOL1 and kidney cell function.

Authors:  Vinod Kumar; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-26

Review 7.  Kidney disease and APOL1.

Authors:  Aminu Abba Yusuf; Melanie A Govender; Jean-Tristan Brandenburg; Cheryl A Winkler
Journal:  Hum Mol Genet       Date:  2021-04-26       Impact factor: 6.150

Review 8.  Chronic kidney disease in low-income to middle-income countries: the case for increased screening.

Authors:  Cindy George; Amelie Mogueo; Ikechi Okpechi; Justin B Echouffo-Tcheugui; Andre Pascal Kengne
Journal:  BMJ Glob Health       Date:  2017-05-29

Review 9.  I too, am America: a review of research on systemic lupus erythematosus in African-Americans.

Authors:  Edith M Williams; Larisa Bruner; Alyssa Adkins; Caroline Vrana; Ayaba Logan; Diane Kamen; James C Oates
Journal:  Lupus Sci Med       Date:  2016-08-24

10.  A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis.

Authors:  Flavio Vincenti; Fernando C Fervenza; Kirk N Campbell; Montserrat Diaz; Loreto Gesualdo; Peter Nelson; Manuel Praga; Jai Radhakrishnan; Lorenz Sellin; Ajay Singh; Denyse Thornley-Brown; Francisco Veríssimo Veronese; Beverly Accomando; Sara Engstrand; Steven Ledbetter; Julie Lin; John Neylan; James Tumlin
Journal:  Kidney Int Rep       Date:  2017-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.